melissa barber of yale university but again, thrust these companies into the spotlight once again for notion of, you know, pharma companies gouging consumers. >> that was a fascinating discussion and you did your part in that, too what's also interesting is that she's done hundreds of studies on drugs since 2016 using the similar algo, and, you know, there's patents, there's a lot of dynamics to think about, but there may be some opportunity to kind of look and see, at what point, other drugs that were this far ahead of their peers and had the ability to price whenever they wanted and at what point there was a price breakage there may be other dynamics that did change the backdrop. >> the other dynamics would seem really obvious, that other competitors -- >> right >> drugs come onto the scene and force price to be lower for this drug >> that was a really interesting melissa/melissa conversation there, but -- >> it was. >> to your point about, how much did they put into this, which, she says, all right, that's not included in the study, that wasn't the point of the study, what is the r